Document is current
Any future updates will be listed below
-
Authors
Berry-Kravis, Elizabeth M. http://orcid.org/0000-0001-7099-1522
Harnett, Mark D.
Reines, Scott A.
Reese, Melody A. http://orcid.org/0000-0002-8288-7914
Ethridge, Lauren E.
Outterson, Abigail H.
Michalak, Claire
Furman, Jeremiah
Gurney, Mark E. http://orcid.org/0000-0003-4901-3083
-
Funding
Funding for this research was provided by:
FRAXA Research Foundation
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD076189)
- License Information
-
More Information
Article History
Received: 24 November 2020
Accepted: 15 March 2021
First Online: 29 April 2021
Competing interests
: E.M.B.-K., L.E.E., M.A.R., A.O., C.M. and J.F. declare no competing interests. M.D.H. and S.D.R. are paid consultants to Tetra Therapeutics. M.E.G. is an employee of Tetra Therapeutics, which is a wholly owned subsidiary of Shionogi & Company that has a financial interest in BPN14770.
